| 发明名称 |
COMBINATION THERAPY OF AN AFUCOSYLATED CD20 ANTIBODY WITH FLUDARABINE AND/OR MITOXANTRONE |
| 摘要 |
<p>The present invention is directed to the combination therapy of an afucosylated anti-CD20 antibody with fludarabine and/or mitoxantrone for the treatment of cancer, especially to the combination therapy of CD20 expressing cancers with an afucosylated humanized B-Ly1 antibody with fludarabine and/or mitoxantrone.</p> |
| 申请公布号 |
KR20120054069(A) |
申请公布日期 |
2012.05.29 |
| 申请号 |
KR20127006531 |
申请日期 |
2010.08.12 |
| 申请人 |
ROCHE GLYCART AG |
发明人 |
DREYLING MARTIN;HEINRICH DANIEL ALEXANDER;HERTING FRANK;KLEIN CHRISTIAN |
| 分类号 |
A61K39/395;A61K31/137;A61K31/70;C07K16/28 |
主分类号 |
A61K39/395 |
| 代理机构 |
|
代理人 |
|
| 主权项 |
|
| 地址 |
|
